Clinical Trial Update: Study of Panobinostat Monotherapy in Women With v-ERB-B2 Avian Erythroblastic Leukemia Viral Oncogene Homolog 2 (HER2) Positive Locally Recurrent or Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial of panobinostat monotherapy in HER2-positive locally recurrent or metastatic breast cancer was terminated, with results posted on 2012-04-10.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Panobinostat (Panobinostat)

Snippet

Sponsor: Translational Research in Oncology | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2012-04-10